Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a new page revision has been published. The update does not modify study details or page content.
    Difference
    0.0%
    Check dated 2026-06-07T15:55:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added, replacing v3.5.3, indicating a routine site update without changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-05-17T09:24:00.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the trial content.
    Difference
    0.0%
    Check dated 2026-04-25T18:42:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:28:20.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-28T01:41:17.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No user-facing content or study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:08.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.